The conference will also include a unique insight into the recent high-profile counterfeit drugs case in the UK, which was successfully resolved with the help of Pfizer and the MHRA. Also, we will get an insight into packaging small orders efficiently from Eli Lilly.

Industry dangers including the constant threat of counterfeit packaging and labelling, and the waves of new business regulations that are changing across Europe are having huge implications to pharmaceutical packaging and labelling strategies. Ensuring drug safety across the supply chain, understanding and complying with the latest regulatory standards for drug labelling, and keeping current on the newest and most pioneering packaging methods technology are just a taste of the issues that will be tackled at SMi’s 4th Pharmaceutical Packaging and Labelling Conference.

SMi’s 4th Pharmaceutical Packaging and Labelling Innovations Conference is the place to be if you want to keep up-to-date with the latest industry developments and network with an international audience of fellow pharmaceutical packaging and labelling professionals.